MeSH term
Frequency | Condition_Probility | Female | 13 | 0.0 |
Humans | 43 | 0.0 |
Pregnancy | 2 | 0.0 |
Acute Disease | 10 | 0.0 |
Amino Acid Sequence | 6 | 0.0 |
Base Sequence | 8 | 0.0 |
Chromosomes, Human, Pair 11/genetics | 5 | 2.0 |
Chromosomes, Human, Pair 7/genetics | 2 | 2.0 |
Homeodomain Proteins/*genetics | 11 | 2.0 |
Leukemia, Myeloid/*genetics | 6 | 4.0 |
Molecular Sequence Data | 10 | 0.0 |
Neoplasm Proteins/genetics | 4 | 0.0 |
Nuclear Pore Complex Proteins/*genetics | 3 | 20.0 |
Research Support, Non-U.S. Gov't | 32 | 0.0 |
Translocation, Genetic/*genetics | 2 | 0.0 |
Animals | 24 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Comparative Study | 3 | 0.0 |
Leukemia, Myeloid/etiology | 2 | 28.0 |
Mice | 22 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Multigene Family | 2 | 0.0 |
Oncogene Proteins, Fusion/genetics/*physiology | 2 | 11.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Recombinant Fusion Proteins/physiology | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 8 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 21 | 0.0 |
Translocation, Genetic | 4 | 0.0 |
Adult | 7 | 0.0 |
Aged | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
*Gene Expression Regulation, Leukemic | 3 | 3.0 |
*Genes, Homeobox | 6 | 2.0 |
Male | 9 | 0.0 |
Middle Aged | 4 | 0.0 |
Neoplasm Proteins/biosynthesis/genetics | 2 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 9 | 0.0 |
Oncogene Proteins, Fusion/*genetics | 4 | 2.0 |
Cell Line, Transformed | 2 | 0.0 |
Homeodomain Proteins/*physiology | 2 | 5.0 |
Subcellular Fractions/metabolism | 2 | 0.0 |
Bone Marrow Cells/metabolism | 2 | 2.0 |
Homeodomain Proteins/*genetics/metabolism | 2 | 2.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
Chromosomes, Human, Pair 4/genetics | 3 | 4.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Infant | 3 | 0.0 |
Leukemia, Lymphocytic, Acute/*genetics | 2 | 2.0 |
Neoplasm Proteins/*genetics | 5 | 0.0 |
*Proto-Oncogenes | 4 | 0.0 |
*Transcription Factors | 4 | 0.0 |
Up-Regulation | 5 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Bone Marrow Transplantation | 3 | 1.0 |
Cell Transformation, Neoplastic/genetics | 2 | 0.0 |
Gene Expression | 3 | 0.0 |
Hematopoietic Stem Cells/*metabolism | 3 | 2.0 |
Homeodomain Proteins/genetics | 3 | 1.0 |
Mice, Inbred C3H | 2 | 0.0 |
Mice, Inbred C57BL | 7 | 0.0 |
*Nuclear Pore Complex Proteins | 4 | 5.0 |
Retroviridae/genetics | 2 | 0.0 |
Transduction, Genetic | 3 | 0.0 |
*Cell Transformation, Neoplastic | 2 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Homeodomain Proteins/genetics/*metabolism | 2 | 1.0 |
Mice, Inbred Strains | 2 | 0.0 |
Neoplasm Proteins/genetics/*metabolism | 2 | 1.0 |
Phenotype | 3 | 0.0 |
Cell Line | 5 | 0.0 |
Homeodomain Proteins/biosynthesis/*genetics | 2 | 9.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Blotting, Western | 3 | 0.0 |
Cytokines/metabolism | 2 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
Homeodomain Proteins/*metabolism | 4 | 3.0 |
Luminescent Proteins/metabolism | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Transfection | 4 | 0.0 |
Genes, Homeobox/*genetics | 3 | 4.0 |
Cell Division/genetics | 2 | 0.0 |
Gene Targeting | 2 | 0.0 |
Homeodomain Proteins/analysis/*genetics | 2 | 22.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
*Chromosomes, Human, Pair 11 | 2 | 0.0 |
Karyotyping | 2 | 0.0 |
Membrane Proteins/*genetics | 2 | 0.0 |
Nuclear Proteins/*genetics | 2 | 0.0 |
*Translocation, Genetic | 4 | 0.0 |
Cell Division | 3 | 0.0 |
Homeodomain Proteins/genetics/*physiology | 2 | 3.0 |
Gene Expression Regulation, Leukemic | 2 | 2.0 |
Leukemia, Myelocytic, Acute/*genetics | 2 | 1.0 |
Protein Conformation | 2 | 0.0 |
Bone Marrow Cells/*metabolism | 3 | 6.0 |
DNA-Binding Proteins/*genetics | 3 | 0.0 |
Neoplasm Proteins/*metabolism | 2 | 0.0 |
U937 Cells | 2 | 0.0 |
Hematopoiesis/*genetics | 2 | 3.0 |
Down-Regulation | 4 | 0.0 |
Homeodomain Proteins/*biosynthesis/genetics | 2 | 7.0 |
Genes, Reporter | 2 | 0.0 |
RNA, Messenger/genetics | 4 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Cell Transplantation | 2 | 2.0 |
Infant, Newborn | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
RNA, Neoplasm/genetics | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Disease Models, Animal | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
RNA, Neoplasm/genetics/metabolism | 2 | 1.0 |
Receptors, Estrogen/genetics/metabolism | 2 | 6.0 |
Bone Marrow Cells/cytology | 2 | 2.0 |
Flow Cytometry | 2 | 0.0 |
Mutation | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
K562 Cells | 2 | 0.0 |
Luciferases/metabolism | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Neoplasm Proteins/*genetics/metabolism | 2 | 1.0 |
